However, the results of the current study suggest that PET imaging may be a good modality for selecting the initial therapeutic plan and possibly optimizing the chance of breast preservation in patients with HR-positive, HER2-negative type (especially luminal B-like type) breast cancer. Here, ERBB2 is linked to breast carcinoma.